Stella Wong > Hogan Lovells International LLP > London, England > Lawyer Profile
Hogan Lovells International LLP Offices
ATLANTIC HOUSE
HOLBORN VIADUCT
LONDON
EC1A 2FG
England
- Firm Profile
- Go to...
Stella Wong
Work Department
Intellectual Property, Media and Technology
Position
Counsel
Career
Stella Wong is dual qualified as a medical doctor and a solicitor. She is a Counsel in the Hogan Lovells London office and works predominantly on multi-jurisdictional patent litigation. Her knowledge in the field of medicine provides particular insights in life sciences cases and she therefore focuses on patent litigation relating to medical device, pharmaceutical and biotechnology patents.
Her recent work highlights include:
- Advising a Fortune 500 medical device company on its global patent litigation strategy in relation to patents for medical imaging.
- Acting for a biopharmaceutical innovator company in its patent litigation involving six patents relating to anaemia.
- Acting for Rhodia (part of the Solvay Group) in its win in a UK patent litigation concerning catalyst/co-catalyst materials for automotive emission control. The case also involved success in: getting the defendant to drop its three experiments/prior art ahead of trial; compelling the production of samples of allegedly infringing material; obtaining an Order that disclosed documents could be used in parallel German proceedings; and obtaining concurrent UK Border Force seizures of infringing material. The appeal was heard earlier this year and the decision is pending.
- Acting in an ICC arbitration for a mobile phone company and advising in related U.S. proceedings.
In the past she has worked on patent litigation for clients such as Eli Lilly, Merck Sharp & Dohme and AGA Medical Corporation (now part of Abbott Laboratories).
Stella has developed a keen interest in the area of 3D printing in the life sciences industry and presented and published on this subject on numerous occasions. She uses her dual qualifications for pro bono work, including most recently for the London Bridge terrorist attack inquest. Stella has qualified as a member of the Royal College of General Practitioners and still practises as a general practitioner every Saturday.
Lawyer Rankings
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
The ‘amazing’ Hogan Lovells International LLP maintains a strong practice in pan-European patent litigation strategy alongside a strong transactional practice. The team is helmed ‘force of nature’ Paul Brown, who is sought out by clients for his expertise in patent-related disputes in the electronics and medical devices sector. ‘Superb’ Stephen Bennett
is also in high demand with pharma companies for his considerable experience in handling disputes. Another notable name is Joel Smith, who has strengths in both contentious and non-contentious matters, with a niche expertise in plant variety protection and regulation. Patent litigator Daniel Brook routinely undertakes cross-border pharma litigation, notably representing Eli Lilly in a dispute regarding its cancer drug pemetrexed. Katie McConnell is noted for her expertise in the telecoms and pharma fields, while Stella Wong focuses on medical device, pharmaceutical and biotechnology patents, balancing her legal practice with her work as a doctor. Counsels Emma Fulton and Dominic Hoar are also recommended.
London > Industry focus > Life sciences and healthcare
The ‘very strong‘ team at Hogan Lovells International LLP assists a varied client base consisting of healthcare, medical device, and pharmaceutical companies with bet-the-company cases and large licensing transactions. Practice co-head Jane Summerfield has vast regulatory expertise spanning clinical trials to reimbursement issues, with particular emphasis on gene therapies and digital health software. Described as ‘Mr. Realistic‘ by clients, patent litigator and co-head Stephen Bennett regularly assists clients with the defence of patents and supplementary certificate rights, while co-head Matthew Felwick is ‘very technical‘ and has deep knowledge surrounding product liability, often acting in group actions and coroner’s inquests. Rated by clients as ‘one of the best life science lawyers in the industry‘, Penny Powell has extensive expertise in M&A and partnering transactions, and counsel Elise Martin is noted for her experience in assisting clients with international regulation and commercial disputes. Having been promoted to partner in January 2023, Stella Wong utilises her medical background to act in disputes concerning biotec, pharmaceutical, and medical device patents.
Lawyer Rankings
- Intellectual property: patents (contentious and non-contentious) London > TMT (technology, media and telecoms)
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
- Public sector > Administrative and public law
- Dispute resolution > Banking litigation: investment and retail
- Corporate and commercial > Commercial contracts
- Dispute resolution > Commercial litigation: premium
- Real estate > Commercial property: corporate occupiers
- Real estate > Commercial property: development
- Risk advisory > Data protection, privacy and cybersecurity
- TMT (technology, media and telecoms) > Fintech
- Crime, fraud and licensing > Fraud: civil
- Projects, energy and natural resources > Infrastructure: Project finance and development
- Insurance > Insurance: corporate and regulatory
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Industry focus > Emerging markets
- Industry focus > Emerging markets
- Industry focus > Life sciences and healthcare
- Investment fund formation and management > Listed funds
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Insurance > Product liability: defendant
- Real estate > Property litigation
- Finance > Trade finance
Firm Rankings
- Real estate > Commercial property: investment
- Dispute resolution > Competition litigation
- Real estate > Construction: contentious
- Real estate > Construction: non-contentious
- Risk advisory > Corporate governance
- Finance > Corporate restructuring & insolvency
- Corporate and commercial > Corporate tax
- Finance > Derivatives and structured products
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: contentious
- Industry focus > Hospitality and leisure
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Dispute resolution > International arbitration
- Projects, energy and natural resources > Oil and gas
- Insurance > Professional negligence
- Real estate > Property finance
- Investment fund formation and management > Real estate funds
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Finance > Securitisation
- Finance > Transport finance and leasing
- Finance > Acquisition finance
- Transport > Aviation
- Finance > Bank lending: investment grade debt and syndicated loans
- Finance > Debt capital markets
- Industry focus > Emerging markets
- Employment > Employee share schemes
- Corporate and commercial > Equity capital markets – mid-large cap
- Corporate and commercial > EU and competition: trade, WTO anti-dumping and customs
- Corporate and commercial > Financial services: non-contentious/regulatory
- Employment > Health and safety
- Finance > High yield
- Insurance > Insurance and reinsurance litigation
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Projects, energy and natural resources > Mining and minerals
- Real estate > Planning
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m)
- Dispute resolution > Public international law
- Transport > Rail
- Dispute resolution > Tax litigation and investigations
- Corporate and commercial > VAT and indirect tax
- Projects, energy and natural resources > Water
- Investment fund formation and management > Fund finance
- Projects, energy and natural resources > Power (including electricity, nuclear and renewables)
- Investment fund formation and management > Private funds
- Employment > Employers
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- TMT (technology, media and telecoms) > Sport
- Corporate and commercial > Equity capital markets – small-mid cap
- Insurance > Insurance litigation: for policyholders